PDF(Pubmed)
Abstract：
UNASSIGNED: Congenital heart defects (CHDs) represent the most prevalent birth defects in China, exhibiting significant mortality and morbidity rates. Recent years have witnessed a steady increase in the occurrence of CHDs, highlighting a crucial need for rigorous research focus.
UNASSIGNED: The cumulative birth prevalence of CHDs in Haidian District from 2013 to 2022 was 80.77 per 10,000 births, reflective of an upward trend primarily influenced by the diagnosis of minor, non-critical congenital defects (non-CCHDs). This increase can be attributed to advancements in diagnostic methodologies. Despite the progress in detection, the survival rate for CHDs did not correspondingly improve.
UNASSIGNED: Policies need to be formulated to promote the graded management of CHDs. There should be timely updates to the diagnostic criteria to align with advancements in diagnostic techniques. Moreover, in instances where therapeutic abortion is not required, the provision of appropriate medical consultation post-diagnosis should be enhanced.
UNASSIGNED: The cumulative birth prevalence of CHDs in Haidian District from 2013 to 2022 was 80.77 per 10,000 births, reflective of an upward trend primarily influenced by the diagnosis of minor, non-critical congenital defects (non-CCHDs). This increase can be attributed to advancements in diagnostic methodologies. Despite the progress in detection, the survival rate for CHDs did not correspondingly improve.
UNASSIGNED: Policies need to be formulated to promote the graded management of CHDs. There should be timely updates to the diagnostic criteria to align with advancements in diagnostic techniques. Moreover, in instances where therapeutic abortion is not required, the provision of appropriate medical consultation post-diagnosis should be enhanced.
摘要：
■先天性心脏病（CHDs）是中国最普遍的出生缺陷，表现出显著的死亡率和发病率。近年来，CHD的发病率稳步上升，突出了严格研究重点的关键需求。
■2013-2022年海淀区CHD累计出生患病率为80.77/万例,反映主要受未成年人诊断影响的上升趋势，非关键先天性缺陷（非CCHD）。这种增加可以归因于诊断方法的进步。尽管在检测方面取得了进展，CHD的生存率没有相应提高.
■需要制定政策以促进CHD的分级管理。应及时更新诊断标准，以适应诊断技术的进步。此外，在不需要治疗性堕胎的情况下，应加强诊断后适当医疗咨询的提供。
■2013-2022年海淀区CHD累计出生患病率为80.77/万例,反映主要受未成年人诊断影响的上升趋势，非关键先天性缺陷（非CCHD）。这种增加可以归因于诊断方法的进步。尽管在检测方面取得了进展，CHD的生存率没有相应提高.
■需要制定政策以促进CHD的分级管理。应及时更新诊断标准，以适应诊断技术的进步。此外，在不需要治疗性堕胎的情况下，应加强诊断后适当医疗咨询的提供。
